393 related articles for article (PubMed ID: 23118256)
1. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related?
Mire SS; Nowell KP; Kubiszyn T; Goin-Kochel RP
Autism; 2014 Nov; 18(8):933-42. PubMed ID: 24031086
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacology of autism spectrum disorder: evidence and practice.
Siegel M
Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):957-73. PubMed ID: 23040909
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
5. Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: perspective from a developing country.
Memari AH; Ziaee V; Beygi S; Moshayedi P; Mirfazeli FS
Res Dev Disabil; 2012; 33(2):563-9. PubMed ID: 22119705
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic medication use in children and adolescents in an inpatient setting.
Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
[TBL] [Abstract][Full Text] [Related]
7. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic medication patterns among youth in foster care.
Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
Houghton R; Liu C; Bolognani F
Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
[TBL] [Abstract][Full Text] [Related]
10. Complementary and alternative medicine use in a large pediatric autism sample.
Perrin JM; Coury DL; Hyman SL; Cole L; Reynolds AM; Clemons T
Pediatrics; 2012 Nov; 130 Suppl 2():S77-82. PubMed ID: 23118257
[TBL] [Abstract][Full Text] [Related]
11. Child, parent, and service predictors of psychotropic polypharmacy among adolescents and young adults with an autism spectrum disorder.
Lake JK; Weiss JA; Dergal J; Lunsky Y
J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):486-93. PubMed ID: 25329798
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic medication use and polypharmacy in children with autism spectrum disorders.
Spencer D; Marshall J; Post B; Kulakodlu M; Newschaffer C; Dennen T; Azocar F; Jain A
Pediatrics; 2013 Nov; 132(5):833-40. PubMed ID: 24144704
[TBL] [Abstract][Full Text] [Related]
13. Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.
Schubart JR; Camacho F; Leslie D
Autism; 2014 Aug; 18(6):631-7. PubMed ID: 24165274
[TBL] [Abstract][Full Text] [Related]
14. Mental health aspects of autistic spectrum disorders in children.
Skokauskas N; Gallagher L
J Intellect Disabil Res; 2012 Mar; 56(3):248-57. PubMed ID: 21554467
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample.
Simonoff E; Pickles A; Charman T; Chandler S; Loucas T; Baird G
J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):921-9. PubMed ID: 18645422
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
Frazier TW; Shattuck PT; Narendorf SC; Cooper BP; Wagner M; Spitznagel EL
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):571-9. PubMed ID: 22166171
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy and children with autism spectrum disorder: a tutorial for speech-language pathologists.
Self TL; Hale LS; Crumrine D
Lang Speech Hear Serv Sch; 2010 Jul; 41(3):367-75. PubMed ID: 20543026
[TBL] [Abstract][Full Text] [Related]
19. Pediatric psychotropic medication initiation and adherence: a literature review based on social exchange theory.
Hamrin V; McCarthy EM; Tyson V
J Child Adolesc Psychiatr Nurs; 2010 Aug; 23(3):151-72. PubMed ID: 20796098
[TBL] [Abstract][Full Text] [Related]
20. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
Radigan M; Lannon P; Roohan P; Gesten F
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
